✉news ScienceBiology first seen 20 h ago, last 12 h ago, peak #12
Polyphron Raises $20M to Predict Drug Toxicity Before Trials
Original: Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials
Biotech startup Polyphron has raised $20 million to develop technology that predicts drug toxicity in human tissue before compounds enter clinical trials. The funding aims to help pharmaceutical companies identify unsafe drug candidates earlier, potentially reducing costly late-stage failures and improving patient safety in drug development.
Why now: The fresh $20 million funding round signals growing investor interest in technology that could cut drug development costs and failures.
Rank over time, top of the chart is #1. 7 snapshots from 20 h ago to 12 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1621602